Low-molecular-weight heparin-conjugated liposomes with improved stability and hemocompatibility

被引:3
|
作者
Köse, GT [1 ]
Arica, MY [1 ]
Hasirci, V [1 ]
机构
[1] Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey
关键词
conjugation; hemocompatibility; liposome stability; low molecular weight heparin; multilamellar liposome;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multilamellar vesicles (MLV) containing phosphatidyl choline (PC), cholestrol (CHOL), and stearylamine (SA) in the molar ratio of 7:2:0.2 were prepared by the thin film hydration method. Low-molecular-weight heparin (LMWH, MW: 3000) was conjugated with the MLV using carbodiimide (EDC), Infrared, Raman, and nuclear magnetic resonance spectra and DSC of each sample (MLV, LMWH, and MLV-LMWH) were obtained, enabling the authors to determine the chemical changes that occurred in the MLV structure at the end of the conjugation step. In addition, the changes in the chemical structures of the conjugated samples were revealed by the use of elemental analysis. Particle size analysis was used to determine the difference between the sizes of MLV and MLV-LMWH. In order to study the effect of LMWH on the behavior of MLV-LMWH in blood, osmotic fragility (in saline and plasma), hemolytic activity, and plasma recalcification time tests were carried out. These tests showed that it was possible to construct liposomes that would not induce reactions in the blood and would have potentially longer half-lives in the circulation.
引用
收藏
页码:257 / 264
页数:8
相关论文
共 50 条
  • [21] ANGIOGENESIS AND LOW-MOLECULAR-WEIGHT HEPARIN
    ROBINSON, LA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (01) : 272 - 273
  • [22] Low-molecular-weight heparin for PE
    Grimm, KJ
    French, L
    JOURNAL OF FAMILY PRACTICE, 1997, 45 (06): : 467 - 468
  • [23] DANAPAROID IS NOT A LOW-MOLECULAR-WEIGHT HEPARIN
    SPINLER, SA
    CZIRAKY, MJ
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (16): : 2050 - 2050
  • [24] Low-molecular-weight heparin in oncology
    Zacharski, LR
    Loynes, JT
    ANTICANCER RESEARCH, 2003, 23 (3C) : 2789 - 2793
  • [25] Dalteparin: A low-molecular-weight heparin
    Howard, PA
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (02) : 192 - 203
  • [26] PHARMACOKINETICS OF UNFRACTIONATED HEPARIN AND OF LOW-MOLECULAR-WEIGHT HEPARIN
    BONEU, B
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 872 - 872
  • [27] Unfractionated heparin or low-molecular-weight heparin in the elderly
    Dorobantu, Maria
    Bogdan, Stefan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 1084 - 1090
  • [28] Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes
    Song, YK
    Kim, CK
    BIOMATERIALS, 2006, 27 (02) : 271 - 280
  • [30] What is a low low-molecular-weight heparin dose?
    Godier, Anne
    Llau, Juan V.
    Ferrandis, Raquel
    Langenecker, Sibylle
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2024, 41 (05)